Anthera Pharmaceuticals, Inc. (ANTH)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 5, 2026, 9:30 AM EST
9,900%
Market Cap 2.62K
Revenue (ttm) n/a
Net Income (ttm) -24.93M
Shares Out 26.18M
EPS (ttm) -1.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 18,307
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0010
Beta -80.00
RSI 52.34
Earnings Date n/a

About Anthera Pharmaceuticals

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21
Stock Exchange OTCMKTS
Ticker Symbol ANTH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.